TrialBMC cancer2021

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).

Jennifer Pascoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.